711 related articles for article (PubMed ID: 19207476)
41. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH
Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074
[TBL] [Abstract][Full Text] [Related]
42. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
43. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch.
Duquesnes N; Vincent F; Morel E; Lezoualc'h F; Crozatier B
Int J Biochem Cell Biol; 2009 May; 41(5):1173-81. PubMed ID: 19015044
[TBL] [Abstract][Full Text] [Related]
44. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Choi EY; Chang W; Lim S; Song BW; Cha MJ; Kim HJ; Choi E; Jang Y; Chung N; Hwang KC
Eur J Pharmacol; 2010 Feb; 627(1-3):56-62. PubMed ID: 19883640
[TBL] [Abstract][Full Text] [Related]
45. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
46. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
47. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
48. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
[TBL] [Abstract][Full Text] [Related]
49. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
[TBL] [Abstract][Full Text] [Related]
50. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia.
Sato T; Morishima Y; Shirasaki Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1042-7. PubMed ID: 12604680
[TBL] [Abstract][Full Text] [Related]
51. Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.
Hirotani S; Higuchi Y; Nishida K; Nakayama H; Yamaguchi O; Hikoso S; Takeda T; Kashiwase K; Watanabe T; Asahi M; Taniike M; Tsujimoto I; Matsumura Y; Sasaki T; Hori M; Otsu K
J Mol Cell Cardiol; 2004 Jun; 36(6):799-807. PubMed ID: 15158121
[TBL] [Abstract][Full Text] [Related]
52. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart.
Fukunaga K; Han F; Shioda N; Moriguchi S; Kasahara J; Shirasaki Y
Cardiovasc Drug Rev; 2006; 24(2):88-100. PubMed ID: 16961723
[TBL] [Abstract][Full Text] [Related]
53. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway.
Yang L; Zou X; Liang Q; Chen H; Feng J; Yan L; Wang Z; Zhou D; Li S; Yao S; Zheng Z
Exp Mol Med; 2007 Feb; 39(1):65-73. PubMed ID: 17334230
[TBL] [Abstract][Full Text] [Related]
54. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
[TBL] [Abstract][Full Text] [Related]
55. Constitutive CaMKII activity regulates Na+ channel in rat ventricular myocytes.
Yoon JY; Ho WK; Kim ST; Cho H
J Mol Cell Cardiol; 2009 Oct; 47(4):475-84. PubMed ID: 19591836
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
[TBL] [Abstract][Full Text] [Related]
57. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
[TBL] [Abstract][Full Text] [Related]
58. Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes.
Kennedy RA; Kemp TJ; Sugden PH; Clerk A
J Mol Cell Cardiol; 2006 Aug; 41(2):236-47. PubMed ID: 16756989
[TBL] [Abstract][Full Text] [Related]
59. Role of mitogen-activated protein kinase kinase in Porphyromonas gingivalis-induced myocardial cell hypertrophy and apoptosis.
Lee SD; Chang SH; Kuo WH; Ying TH; Kuo WW; Li PC; Hsu HH; Lu MC; Ting H; Huang CY
Eur J Oral Sci; 2006 Apr; 114(2):154-9. PubMed ID: 16630308
[TBL] [Abstract][Full Text] [Related]
60. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
